|
HS Code |
187459 |
| Name | Azetidine |
| Molecular Formula | C3H7N |
| Molar Mass | 57.09 g/mol |
| Appearance | Colorless liquid |
| Density | 0.847 g/cm3 |
| Boiling Point | 63-66 °C |
| Melting Point | -51 °C |
| Cas Number | 503-29-7 |
| Structure | Four-membered saturated heterocycle |
| Solubility In Water | Miscible |
| Odor | Amine-like |
| Refractive Index | 1.423 |
| Pka | 11.3 |
| Hazard Statements | Flammable, harmful if inhaled |
| Synonyms | Trimethyleneimine |
As an accredited Azetidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Azetidine is packaged in a 100g amber glass bottle with a tight-sealed screw cap, labeled with hazard information and purity details. |
| Shipping | Azetidine is shipped in tightly sealed containers under inert atmosphere, away from heat, sparks, and open flames, due to its flammable and volatile nature. Packaging complies with chemical safety regulations, ensuring protection from moisture and contamination. Appropriate hazard labeling and documentation accompany each shipment per international transport guidelines. |
| Storage | Azetidine should be stored in a tightly sealed container under an inert atmosphere, such as nitrogen or argon, to prevent moisture and air exposure. It should be kept in a cool, dry, and well-ventilated area, away from sources of ignition, heat, and incompatible substances (such as strong oxidizers and acids), as it is flammable and may decompose on exposure to air or light. |
Applications of Azetidine in Industrial ManufacturingAs a core chemical building block, Azetidine plays a critical role in a narrow range of high-impact industrial sectors where its four-membered nitrogen ring supports advanced synthesis pathways. Below we detail the primary downstream scenarios that reliably depend on our high-purity product, with specific focus on practical use factors and manufacturing context. 1. Active Pharmaceutical Ingredient (API) Synthesis – β-Lactam AntibioticsMajor pharmaceutical manufacturers employ Azetidine as a structural synthon in β-lactam core antibiotic production, leveraging the strained ring system in multistep reactions for cephalosporins and carbapenems. Its use is restricted to GMP environments, where batch controls and impurity profiles receive stringent validation. The integration phase typically occurs during the protected intermediate stage, where precise molar equivalents are required for ring assembly without yield-compromising side reactions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Advanced Agrochemical Intermediates – Herbicide SynthesisLeading agricultural chemical producers incorporate Azetidine as a key intermediate during the generation of selective herbicides, especially those based on azetidinyl-acetate or pyrrolidone motifs. Its entry point emerges during the heterocycle installation phase, which requires both high purity and controlled stoichiometry to limit non-target byproducts impacting field efficacy. The finished actives undergo environmental and residue testing aligned with market-specific agrochemical regulations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Specialty Polymer Precursors – Performance PolyimidesIn the engineering plastics sector, polymer manufacturers utilize azetidine-based monomers to enhance thermal resistance and flexibility in advanced polyimide formulations. The integration process demands controlled co-monomer feed ratios, where trace moisture and residual solvents can disrupt polymer chain extension. Manufacturers coordinate exclusively with industrial QC labs to document input ratios and chain termination events, ensuring that batch-to-batch consistency is traceable for downstream fiber spinning or film casting lines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Fine Chemical Synthesis – Chiral Auxiliary AgentsProducers of chiral chemicals and specialty reagents rely on Azetidine as a platform molecule for constructing enantioselective auxiliaries, typically deployed in asymmetric synthesis lines supporting pharmaceutical and fragrance intermediate manufacture. The fine chemical process requires rigorous control over ring-opening and functionalization chemistry, with GC/HPLC purity confirmation before downstream hand-off. Batch records must align with ISO and cGMP traceability protocols for custom synthesis clients. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Azetidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Azetidine stands out in the world of heterocyclic chemistry for its unique structure and the reactivity it brings to advanced manufacturing. As a producer with decades in the field, we see firsthand how the four-membered ring of azetidine changes the way chemists approach tough synthetic challenges. Rather than following the same path laid out by more common ring systems, azetidine’s nitrogen atom and strained backbone open new doors for our partners in pharmaceuticals, agrochemicals, and specialty polymer development. Each year, requests grow for materials that push property boundaries—demands that standard building blocks like pyrrolidine or piperidine can’t match. Our experience with azetidine tells a different story.
Most of the practical value in azetidine comes from the tension hiding in that small ring system. Strain in the molecule may seem like a technical quirk, but for those of us handling day-to-day process chemistry, it’s a lever. The ring tension means azetidine reacts more eagerly than its five- and six-membered cousins. Where piperidine and morpholine resist attack, azetidine can step up as a highly functionalized intermediate. In many cases, switching a scaffold or intermediate from a larger ring to azetidine cuts down reaction times, opens new routes for bond formation, and creates derivatives that hold up under harsher conditions. Chemists in drug discovery quickly recognize this advantage after seeing more rigid and spatially efficient pharmacophores emerge from azetidine-based analogues.
We’ve learned through trial and adjustment that not every existing synthesis adapts smoothly to this molecule. Yet, those who persist find reward—a modest azetidine derivative, when slipped into early pharmaceutical scaffolds, often shapes new routes for bioactivity. Working directly with development teams, we’ve tweaked parameters to deliver azetidine with the low moisture content and high purity demanded by modern medicinal chemistry, recognizing that even tiny traces of residual water disrupt complex amine chemistry. R&D teams come to us not for “off-the-shelf” volumes but for trustworthy batches, consistently produced and handled with care.
Manufacturing azetidine calls for more hands-on process control than most amines in its class. We rely on closed-system synthesis to keep air and water away during isolation. Distillation happens under inert atmosphere. Our production lines operate under continuous monitoring, not because it looks good on paper, but because a deviation in purity or ring-opened byproducts can bring entire research projects to a halt. Years ago, bringing azetidine into pilot scale uncovered shelf life challenges; we responded with advanced bottling techniques, nitrogen backfilling, and new sealed packaging. These aren’t minor upgrades—they grew from repeated requests by partners who couldn’t afford unpredictable results.
We track every shipment down to the hour, not only as a reliability benchmark but as a promise to chemists facing tight project timelines. When a pharmaceutical or polymer team designs a route around such a reactive building block, they don’t want last-minute surprises held up by missed delivery windows. We heard frequent frustration about imported stock from distant traders: “odd color, variable odor” or worse, “batch-to-batch inconsistency.” As a direct manufacturer, we own every step from precursor selection to shipment, so the feedback loop is short—problems reach our lab, not a desk a continent away.
Our strongest demand comes from pharmaceutical R&D, and for good reason. Adding the azetidine ring transforms the three-dimensional shape of a molecule, often giving pharmacologists the chance to optimize solubility without adding excessive weight or flexible atoms. Years back, one of our top customers struggled with analogues that showed promise in cell lines but failed in animal models due to rapid oxidation; exchanging a morpholine group for an azetidine core rebalanced that chemistry. Stereoelectronics and metabolic stability are buzzwords until you see real-world differences in clearance or target binding—differences that often make or break a project.
Polymers built on azetidine derivatives show meaningful improvement in elasticity or heat resistance compared to older formulations. Our plant’s technical team routinely works with downstream users to tune impurity profiles to fit emerging composite requirements in electronics. For surface coatings and electronics, batch-to-batch predictability is just as important—our engineers learned that the hard way from projects derailed mid-launch by an off-specification shipment. Every kilogram carries the legacy of these lessons, setting us apart from less responsive suppliers.
Direct comparisons between azetidine and more common cyclic amines reveal a sharp difference in both handling and performance. Cyclobutane derivatives lack the extra reactivity the nitrogen atom brings. Piperidine and pyrrolidine, popular for their easy availability, look tame in comparison to azetidine’s ring strain and basicity. The smaller ring shrinks steric bulk, enabling chemists to reach otherwise tough sites or minimize steric clashes in densely functionalized molecules. Feedback from medicinal chemists confirms what we see in the pilot plant: a small change at the monomer level echoes through the final compound, not always justifying the easiest route, but nearly always opening new property windows.
We worked with a polymer company last year exploring high-performance coatings. Their approach used azetidine as a crosslinker, leaning into the ring strain as an advantage. No off-the-shelf commodity could match the flexibility or resilience in finished films. In drug design, chemists chasing novel CNS-active scaffolds often find that small azetidine core makes metabolic deactivation a little less of a risk. These are advantages that don’t always surface in spreadsheets or cost-benefit analyses—they suggest the right answer sometimes takes a bit more risk, both in supply and process development. We help smooth that path with technical support grounded in real plant feedback, not just literature references.
From the point of view of a chemical producer, moving azetidine out of the lab and into steady production forced us to solve hands-on safety and scale-up issues. Strong odors and volatility forced us to invest early-on in air-handling and closed-system transfer. Disposal of ring-opened impurities proved stubborn. We learned to monitor our reactors by GC every few hours, and made quality overseers part of the process floor, not remote departments. By focusing on process innovation—like multilayer steel reactors, low-temperature columns, and real-time analysis—we mastered the jump from a 50-gram flask to multiple metric tons per year.
Our on-site regulatory officers keep close tabs on compliance and reporting, because this molecule isn’t one to be handled lightly, especially under local and international transport statutes. We maintain records of every output, not for bureaucratic comfort, but because scientists and project managers expect traceability. We don’t treat this as “best effort” logistics—an error in batch labeling or delayed customs paperwork can destroy months of hard work. Direct relationships with regulatory auditors, customs brokers, and freight partners allow us to forecast deliveries with realistic precision.
We noticed early on that azetidine’s best potential shines through when pairing process capabilities with a willingness to solve custom problems. Sometimes a pharmaceutical team needs ultra-high purity azetidine, scrupulously free from trace methylamines or aldehydes. Sometimes a coatings manufacturer wants a blend with other cyclic amines for tailored crosslinking. Our synthesis pathways can pivot to greener reagents and less hazardous isolations for customers pushing for sustainability. We take pride in serving as a hands-on extension for their R&D goals. There’s no generic one-size-fits-all here—open feedback cycles with our customers keep our formulation and technical teams nimble.
Several years back, a specialty chemical developer required an azetidine downstream product with unusual halide content, pushing our reactors and purification lines to their practical limits. Instead of sending out a list of standard stock, we brought engineers from both sides together at our site. By inviting real technicians, safety managers, and QC leads to the table, we mapped out a practical solution that reduced waste and improved yield—a collaboration only possible by being the actual producer and not a distant vendor. Partnerships like these underscore the deeper strengths manufacturers bring to sensitive and technically demanding chemistries.
Every variable in production, storage, and delivery matters more with complex building blocks like azetidine. Supplying the right product means listening closely to feedback from the chemists and engineers who depend on our production for their own long-term innovation. We invest consistently in real-world pilot tests and batch sampling, working side-by-side with custom synthesis shops as well as major pharmaceutical groups. This close feedback loop lets us stay ahead of subtle shifts in market demand or regulatory status—never taking a business-as-usual approach for granted.
Over the past decade, several of our customers chose new process routes around azetidine, citing the molecule’s versatility both for small-volume discovery runs and for large-scale launches. At each stage, the requirements shifted: a new ligand for palladium catalysis, a monomer for a unique elastomer, a raw material with certified traceability. Each project forced us to push the boundaries of what our plant and technical teams could deliver, and in doing so, we came to understand that a manufacturer’s value shows up in every batch, not just at the contract’s signoff.
The learning curve doesn’t end. A decade ago, only a few specialists would have selected azetidine as a mainline intermediate. Growing familiarity, paired with our willingness to adopt new purification, safety, and delivery methods, made wider adoption possible. Direct conversations with clients about process pinch points led to upgrades in reactor design, improved inline sensors, and faster troubleshooting. The result is a product line that doesn’t just fill out a catalog, but actually drives innovation from the bench all the way to commercial launch.
We still see untapped promise for azetidine across divergent industries. Our technical teams keep a close eye on developments in battery electrolytes, new-generation adhesives, and novel bioactive compounds. Each sector brings a fresh list of demands; some ask for absolute consistency, others for flexibility and technical responsiveness. Years of partnership with innovators showed us that no two uses for azetidine look identical, and every application benefits from a real dialogue between user and maker.
Our role isn’t to push an anonymous molecule, but to share our accumulated know-how and respond to the unexpected issues that surface on the front lines of synthesis. We see our partners succeed when they can pick up the phone, explain a yield drop or purity question, and get answers from someone who understands real-world production—not canned responses. Unvarnished, technical support is what built our customer base and established our credibility with regulators and project managers alike. We back process reliability with data drawn from years of production runs, detailed batch records, and a commitment to full transparency should a problem arise.
In our experience, the best innovations emerge not just from exciting chemistry, but also from rigorous attention to every step of the supply chain. Molecules like azetidine set a higher bar that tests both technical capability and responsiveness. Handling its challenges showed us just how much value we can deliver by meeting customers where they are, rather than dictating rigid terms or one-off offerings. In an environment where quality, documentation, and human insight matter, being the real manufacturer makes the difference.
The next generation of chemical applications demands exactly this level of focus. Bringing azetidine from concept to application depends on trust, repeatability, and readiness to tackle the unknown. For every kilogram shipped, years of process improvements, direct problem solving, and real-world testing ride along. By putting our experience on the table—good and bad—we help open new frontiers for chemists, industrial innovators, and all those working to make something truly new.